Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 6.02503119 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.64071284 |
3 | locomotory exploration behavior (GO:0035641) | 5.41309159 |
4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.09349958 |
5 | sodium ion export (GO:0071436) | 4.64014263 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.58797871 |
7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.54543393 |
8 | glutamate secretion (GO:0014047) | 4.47958634 |
9 | regulation of synapse structural plasticity (GO:0051823) | 4.37372554 |
10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.33478041 |
11 | layer formation in cerebral cortex (GO:0021819) | 4.16810724 |
12 | synaptic vesicle exocytosis (GO:0016079) | 4.13416999 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.07581584 |
14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.05068685 |
15 | vocalization behavior (GO:0071625) | 4.00933913 |
16 | mannose metabolic process (GO:0006013) | 3.98085058 |
17 | activation of protein kinase A activity (GO:0034199) | 3.97405054 |
18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.96649239 |
19 | cellular potassium ion homeostasis (GO:0030007) | 3.96521288 |
20 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91610461 |
21 | proline transport (GO:0015824) | 3.86380448 |
22 | neurotransmitter secretion (GO:0007269) | 3.85961083 |
23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.81759582 |
24 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.79448210 |
25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.76028374 |
26 | neuromuscular process controlling balance (GO:0050885) | 3.74390354 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72501645 |
28 | negative regulation of cell killing (GO:0031342) | 3.72501645 |
29 | exploration behavior (GO:0035640) | 3.70715089 |
30 | cell communication by electrical coupling (GO:0010644) | 3.64581973 |
31 | regulation of ARF protein signal transduction (GO:0032012) | 3.62665270 |
32 | regulation of synaptic vesicle transport (GO:1902803) | 3.61545997 |
33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.59891793 |
34 | gamma-aminobutyric acid transport (GO:0015812) | 3.59119089 |
35 | dendritic spine morphogenesis (GO:0060997) | 3.57686541 |
36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57409162 |
37 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.52352873 |
38 | positive regulation of synapse maturation (GO:0090129) | 3.34226070 |
39 | neuromuscular process controlling posture (GO:0050884) | 3.32503517 |
40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.31338382 |
41 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.31159758 |
42 | alanine transport (GO:0032328) | 3.29130504 |
43 | regulation of ARF GTPase activity (GO:0032312) | 3.23950508 |
44 | glycine transport (GO:0015816) | 3.22495761 |
45 | cerebellar Purkinje cell layer development (GO:0021680) | 3.21773209 |
46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20524709 |
47 | potassium ion import (GO:0010107) | 3.18652596 |
48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15773493 |
49 | long-term memory (GO:0007616) | 3.14239160 |
50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.11100512 |
51 | neuronal action potential propagation (GO:0019227) | 3.10737434 |
52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09603272 |
53 | vesicle transport along microtubule (GO:0047496) | 3.08245654 |
54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.06982543 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06459328 |
56 | cellular sodium ion homeostasis (GO:0006883) | 3.05831138 |
57 | positive thymic T cell selection (GO:0045059) | 3.02497058 |
58 | protein localization to synapse (GO:0035418) | 3.00980597 |
59 | negative regulation of myotube differentiation (GO:0010832) | 3.00213861 |
60 | adherens junction assembly (GO:0034333) | 2.95573446 |
61 | synaptic transmission, glutamatergic (GO:0035249) | 2.95531080 |
62 | cell-substrate adherens junction assembly (GO:0007045) | 2.94555032 |
63 | focal adhesion assembly (GO:0048041) | 2.94555032 |
64 | thymic T cell selection (GO:0045061) | 2.94509477 |
65 | prepulse inhibition (GO:0060134) | 2.93045886 |
66 | synaptic vesicle endocytosis (GO:0048488) | 2.91395604 |
67 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90926726 |
68 | establishment of nucleus localization (GO:0040023) | 2.90909809 |
69 | positive regulation of membrane potential (GO:0045838) | 2.89907862 |
70 | regulation of synaptic plasticity (GO:0048167) | 2.89133150 |
71 | positive regulation of histone deacetylation (GO:0031065) | 2.89104702 |
72 | neurotransmitter transport (GO:0006836) | 2.83902784 |
73 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.83641482 |
74 | dendrite morphogenesis (GO:0048813) | 2.83244294 |
75 | apoptotic process involved in morphogenesis (GO:0060561) | 2.80609809 |
76 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.77378749 |
77 | positive regulation of receptor recycling (GO:0001921) | 2.76719218 |
78 | membrane depolarization during action potential (GO:0086010) | 2.76092249 |
79 | regulation of extracellular matrix disassembly (GO:0010715) | 2.75980497 |
80 | regulation of neurotransmitter levels (GO:0001505) | 2.75959583 |
81 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.75905309 |
82 | cell migration in hindbrain (GO:0021535) | 2.75765770 |
83 | semaphorin-plexin signaling pathway (GO:0071526) | 2.74360801 |
84 | creatine metabolic process (GO:0006600) | 2.73963140 |
85 | activation of JUN kinase activity (GO:0007257) | 2.72000075 |
86 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.71710073 |
87 | response to auditory stimulus (GO:0010996) | 2.71151597 |
88 | positive regulation of myotube differentiation (GO:0010831) | 2.68759340 |
89 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.67587361 |
90 | histone H4 deacetylation (GO:0070933) | 2.67271741 |
91 | dendritic spine organization (GO:0097061) | 2.67133425 |
92 | glutamate receptor signaling pathway (GO:0007215) | 2.65840834 |
93 | barbed-end actin filament capping (GO:0051016) | 2.65647512 |
94 | clathrin coat assembly (GO:0048268) | 2.63425891 |
95 | organelle transport along microtubule (GO:0072384) | 2.63023647 |
96 | dopamine receptor signaling pathway (GO:0007212) | 2.62162281 |
97 | cell communication involved in cardiac conduction (GO:0086065) | 2.61947238 |
98 | auditory behavior (GO:0031223) | 2.61853545 |
99 | neuronal ion channel clustering (GO:0045161) | 2.61594985 |
100 | neuromuscular process (GO:0050905) | 2.61579412 |
101 | signal complex assembly (GO:0007172) | 2.61407112 |
102 | stress fiber assembly (GO:0043149) | 2.60196854 |
103 | peptidyl-lysine dimethylation (GO:0018027) | 2.59561846 |
104 | response to laminar fluid shear stress (GO:0034616) | 2.58408858 |
105 | regulation of postsynaptic membrane potential (GO:0060078) | 2.57718165 |
106 | positive regulation of Rap GTPase activity (GO:0032854) | 2.57635216 |
107 | atrioventricular valve morphogenesis (GO:0003181) | 2.57113869 |
108 | potassium ion homeostasis (GO:0055075) | 2.56572244 |
109 | regulation of Rap GTPase activity (GO:0032317) | 2.54131089 |
110 | leukocyte aggregation (GO:0070486) | 2.53923255 |
111 | neuron-neuron synaptic transmission (GO:0007270) | 2.53920137 |
112 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.53372593 |
113 | germinal center formation (GO:0002467) | 2.52885257 |
114 | activation of MAPKKK activity (GO:0000185) | 2.51504306 |
115 | actin-myosin filament sliding (GO:0033275) | 2.50720943 |
116 | muscle filament sliding (GO:0030049) | 2.50720943 |
117 | membrane repolarization (GO:0086009) | 2.47421380 |
118 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.46658475 |
119 | regulation of neurotransmitter secretion (GO:0046928) | 2.45379633 |
120 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.45049670 |
121 | macroautophagy (GO:0016236) | 2.43876442 |
122 | cell-substrate junction assembly (GO:0007044) | 2.42839005 |
123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.42199917 |
124 | response to muramyl dipeptide (GO:0032495) | 2.41772653 |
125 | positive regulation of dendritic spine development (GO:0060999) | 2.41022005 |
126 | detection of bacterium (GO:0016045) | 2.40911021 |
127 | axon cargo transport (GO:0008088) | 2.40787367 |
128 | mating behavior (GO:0007617) | 2.40171133 |
129 | cell-cell junction maintenance (GO:0045217) | 2.39350692 |
130 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.39324250 |
131 | regulation of female receptivity (GO:0045924) | 2.38849345 |
132 | membrane depolarization (GO:0051899) | 2.38477536 |
133 | histone H3 deacetylation (GO:0070932) | 2.38380629 |
134 | regulation of necroptotic process (GO:0060544) | 2.38111705 |
135 | positive regulation of fibroblast migration (GO:0010763) | 2.37258740 |
136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.37190228 |
137 | positive regulation of protein dephosphorylation (GO:0035307) | 2.36607426 |
138 | long-term synaptic potentiation (GO:0060291) | 2.36601091 |
139 | negative regulation of cell size (GO:0045792) | 2.36258692 |
140 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.36131782 |
141 | cAMP biosynthetic process (GO:0006171) | 2.35600794 |
142 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.35329127 |
143 | negative regulation of necroptotic process (GO:0060546) | 2.34540918 |
144 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.33472738 |
145 | myofibril assembly (GO:0030239) | 2.33088084 |
146 | positive regulation of protein deacetylation (GO:0090312) | 2.32283007 |
147 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.30073403 |
148 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.29822722 |
149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.29597142 |
150 | detection of other organism (GO:0098543) | 2.29464862 |
151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.29228571 |
152 | cardiac muscle contraction (GO:0060048) | 2.28540844 |
153 | activation of Rac GTPase activity (GO:0032863) | 2.28410047 |
154 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.26977124 |
155 | protein localization to endosome (GO:0036010) | 2.26407969 |
156 | macrophage activation involved in immune response (GO:0002281) | 2.26259221 |
157 | skeletal muscle contraction (GO:0003009) | 2.25671152 |
158 | cardiac myofibril assembly (GO:0055003) | 2.25377677 |
159 | endothelial cell chemotaxis (GO:0035767) | 2.25052006 |
160 | T cell selection (GO:0045058) | 2.25001693 |
161 | protein targeting to plasma membrane (GO:0072661) | 2.24605476 |
162 | regulation of gamma-delta T cell activation (GO:0046643) | 2.24099572 |
163 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.23495240 |
164 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.23147643 |
165 | regulation of early endosome to late endosome transport (GO:2000641) | 2.22188824 |
166 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.21882109 |
167 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.21176706 |
168 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.20360923 |
169 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.16749547 |
170 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.11130296 |
171 | cell volume homeostasis (GO:0006884) | 2.11104622 |
172 | skeletal muscle adaptation (GO:0043501) | 2.10995977 |
173 | venous blood vessel morphogenesis (GO:0048845) | 2.10935178 |
174 | response to fluid shear stress (GO:0034405) | 2.10278003 |
175 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.08282553 |
176 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.07742114 |
177 | regulation of leukocyte degranulation (GO:0043300) | 2.07213894 |
178 | positive regulation of protein kinase C signaling (GO:0090037) | 2.06785701 |
179 | negative regulation of fatty acid transport (GO:2000192) | 2.06779765 |
180 | striated muscle contraction (GO:0006941) | 2.06061120 |
181 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.05322797 |
182 | positive T cell selection (GO:0043368) | 2.04548955 |
183 | modulation by symbiont of host cellular process (GO:0044068) | 2.04401533 |
184 | basement membrane organization (GO:0071711) | 2.03650570 |
185 | negative thymic T cell selection (GO:0045060) | 2.03321819 |
186 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.02761724 |
187 | negative regulation of necrotic cell death (GO:0060547) | 2.02713661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.48138905 |
2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.32303784 |
3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.91583781 |
4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.90488665 |
5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.87757649 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.75455601 |
7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29226381 |
8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21289257 |
9 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.20203459 |
10 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.19911199 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.18548825 |
12 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.16375087 |
13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12287815 |
14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09558070 |
15 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.09412017 |
16 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.98781189 |
17 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96938979 |
18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96788600 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91546119 |
20 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.90600081 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90218568 |
22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90142351 |
23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88460826 |
24 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.88112291 |
25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86677625 |
26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86625226 |
27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86625226 |
28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81134581 |
29 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.81060987 |
30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.79341455 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76618634 |
32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73719931 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72102188 |
34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72006428 |
35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67667963 |
36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66637873 |
37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65101154 |
38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65045972 |
39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64995032 |
40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63469361 |
41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60329535 |
42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60085632 |
43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.59586385 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59337835 |
45 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56474058 |
46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56125437 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54187081 |
48 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.53691055 |
49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51651070 |
50 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49977048 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48992569 |
52 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47730519 |
53 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.45115964 |
54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43826681 |
55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43431660 |
56 | * MAF_26560356_Chip-Seq_TH2_Human | 1.41224772 |
57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40450173 |
58 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.40315474 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39771023 |
60 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39654958 |
61 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38139242 |
62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36551322 |
63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36246367 |
64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35942850 |
65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35872429 |
66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35851556 |
67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35404090 |
68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.34642682 |
69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33803002 |
70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33581373 |
71 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.31370397 |
72 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31150188 |
73 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30610738 |
74 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.29873820 |
75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28767118 |
76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28194876 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.25221886 |
78 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.23931428 |
79 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.22431389 |
80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21021611 |
81 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20213501 |
82 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19672412 |
83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18993400 |
84 | * P68_20966046_ChIP-Seq_HELA_Human | 1.18973434 |
85 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.18215643 |
86 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17748317 |
87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15457495 |
88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13298924 |
89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13030705 |
90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12665404 |
91 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.12062644 |
92 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11327936 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10782814 |
94 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08788448 |
95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07655722 |
96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07655722 |
97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07461824 |
98 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 1.07154000 |
99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06878580 |
100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06687304 |
101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06470190 |
102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06464133 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05803805 |
104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05698491 |
105 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05552797 |
106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05278566 |
107 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05083598 |
108 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04991708 |
109 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02693265 |
110 | AR_19668381_ChIP-Seq_PC3_Human | 1.01948802 |
111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01268065 |
112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00347677 |
113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00254530 |
114 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99633064 |
115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99472837 |
116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99001614 |
117 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98756469 |
118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98635677 |
119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98195725 |
120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98109389 |
121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98023008 |
122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97506003 |
123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97146606 |
124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97132608 |
125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97015509 |
126 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96947930 |
127 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96342415 |
128 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95046837 |
129 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93907386 |
130 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93057145 |
131 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91336586 |
132 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90879066 |
133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90168882 |
134 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89360527 |
135 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88671876 |
136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87898029 |
137 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.87673298 |
138 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86666706 |
139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85941388 |
140 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85751125 |
141 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.85443574 |
142 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85233640 |
143 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83621253 |
144 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83310336 |
145 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83296307 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.03195923 |
2 | MP0003635_abnormal_synaptic_transmissio | 3.76925964 |
3 | MP0002822_catalepsy | 2.88324573 |
4 | MP0004270_analgesia | 2.84127996 |
5 | MP0002909_abnormal_adrenal_gland | 2.83339999 |
6 | MP0005451_abnormal_body_composition | 2.82592858 |
7 | MP0002063_abnormal_learning/memory/cond | 2.80189836 |
8 | MP0009745_abnormal_behavioral_response | 2.69937108 |
9 | MP0002064_seizures | 2.69464475 |
10 | MP0009780_abnormal_chondrocyte_physiolo | 2.57567341 |
11 | MP0004858_abnormal_nervous_system | 2.52751698 |
12 | MP0008961_abnormal_basal_metabolism | 2.51924109 |
13 | MP0003436_decreased_susceptibility_to | 2.48516203 |
14 | MP0009046_muscle_twitch | 2.48331488 |
15 | MP0003329_amyloid_beta_deposits | 2.43214116 |
16 | MP0003172_abnormal_lysosome_physiology | 2.28501623 |
17 | MP0003283_abnormal_digestive_organ | 2.28177632 |
18 | MP0008260_abnormal_autophagy | 2.23972446 |
19 | MP0003880_abnormal_central_pattern | 2.15940832 |
20 | MP0002572_abnormal_emotion/affect_behav | 2.13654401 |
21 | MP0001958_emphysema | 2.07494176 |
22 | MP0003279_aneurysm | 2.03913396 |
23 | MP0010234_abnormal_vibrissa_follicle | 2.03759768 |
24 | MP0008438_abnormal_cutaneous_collagen | 1.96000064 |
25 | MP0000569_abnormal_digit_pigmentation | 1.95860298 |
26 | MP0003075_altered_response_to | 1.90707417 |
27 | MP0004885_abnormal_endolymph | 1.87738738 |
28 | MP0001486_abnormal_startle_reflex | 1.85598060 |
29 | MP0008569_lethality_at_weaning | 1.84480922 |
30 | MP0004036_abnormal_muscle_relaxation | 1.84101405 |
31 | MP0004811_abnormal_neuron_physiology | 1.82177925 |
32 | MP0001968_abnormal_touch/_nociception | 1.81564896 |
33 | MP0005423_abnormal_somatic_nervous | 1.81307638 |
34 | MP0000751_myopathy | 1.81082121 |
35 | MP0002272_abnormal_nervous_system | 1.81010709 |
36 | MP0004130_abnormal_muscle_cell | 1.79233999 |
37 | MP0009278_abnormal_bone_marrow | 1.74870661 |
38 | MP0000749_muscle_degeneration | 1.69897453 |
39 | MP0002249_abnormal_larynx_morphology | 1.68630306 |
40 | MP0000759_abnormal_skeletal_muscle | 1.63858750 |
41 | MP0002933_joint_inflammation | 1.63566893 |
42 | MP0002734_abnormal_mechanical_nocicepti | 1.63192364 |
43 | MP0001501_abnormal_sleep_pattern | 1.62976785 |
44 | MP0003633_abnormal_nervous_system | 1.59884023 |
45 | MP0002733_abnormal_thermal_nociception | 1.57338772 |
46 | MP0000604_amyloidosis | 1.50464955 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.49074081 |
48 | MP0003705_abnormal_hypodermis_morpholog | 1.47833670 |
49 | MP0005409_darkened_coat_color | 1.47520397 |
50 | MP0004947_skin_inflammation | 1.45399867 |
51 | MP0006082_CNS_inflammation | 1.44464504 |
52 | MP0000733_abnormal_muscle_development | 1.44148160 |
53 | MP0005330_cardiomyopathy | 1.43850563 |
54 | MP0000013_abnormal_adipose_tissue | 1.43455987 |
55 | MP0001440_abnormal_grooming_behavior | 1.42902709 |
56 | MP0000955_abnormal_spinal_cord | 1.42687044 |
57 | MP0003724_increased_susceptibility_to | 1.42261378 |
58 | MP0004185_abnormal_adipocyte_glucose | 1.41999520 |
59 | MP0003763_abnormal_thymus_physiology | 1.40946652 |
60 | MP0000678_abnormal_parathyroid_gland | 1.40000328 |
61 | MP0006138_congestive_heart_failure | 1.39461876 |
62 | MP0003879_abnormal_hair_cell | 1.38688204 |
63 | MP0003566_abnormal_cell_adhesion | 1.38092818 |
64 | MP0003690_abnormal_glial_cell | 1.36768645 |
65 | MP0001970_abnormal_pain_threshold | 1.36167661 |
66 | MP0004084_abnormal_cardiac_muscle | 1.33194279 |
67 | MP0003091_abnormal_cell_migration | 1.31601831 |
68 | MP0009840_abnormal_foam_cell | 1.30439551 |
69 | MP0004924_abnormal_behavior | 1.29188869 |
70 | MP0005386_behavior/neurological_phenoty | 1.29188869 |
71 | MP0008874_decreased_physiological_sensi | 1.28664311 |
72 | MP0002557_abnormal_social/conspecific_i | 1.28452716 |
73 | MP0002998_abnormal_bone_remodeling | 1.27318347 |
74 | MP0003646_muscle_fatigue | 1.26273748 |
75 | MP0002106_abnormal_muscle_physiology | 1.25928115 |
76 | MP0003453_abnormal_keratinocyte_physiol | 1.24748228 |
77 | MP0002067_abnormal_sensory_capabilities | 1.24442136 |
78 | MP0002736_abnormal_nociception_after | 1.22121998 |
79 | MP0000750_abnormal_muscle_regeneration | 1.20323197 |
80 | MP0004510_myositis | 1.19799448 |
81 | MP0000747_muscle_weakness | 1.18900924 |
82 | MP0001533_abnormal_skeleton_physiology | 1.18306022 |
83 | MP0010630_abnormal_cardiac_muscle | 1.17588315 |
84 | MP0005025_abnormal_response_to | 1.17162765 |
85 | MP0003631_nervous_system_phenotype | 1.16328832 |
86 | MP0002419_abnormal_innate_immunity | 1.16297720 |
87 | MP0002066_abnormal_motor_capabilities/c | 1.15780984 |
88 | MP0002332_abnormal_exercise_endurance | 1.11241343 |
89 | MP0005503_abnormal_tendon_morphology | 1.11121875 |
90 | MP0005369_muscle_phenotype | 1.10729009 |
91 | MP0002184_abnormal_innervation | 1.08245431 |
92 | MP0000767_abnormal_smooth_muscle | 1.08136744 |
93 | MP0009384_cardiac_valve_regurgitation | 1.08062283 |
94 | MP0003045_fibrosis | 1.08009195 |
95 | MP0004381_abnormal_hair_follicle | 1.06913225 |
96 | MP0002108_abnormal_muscle_morphology | 1.05647642 |
97 | MP0001873_stomach_inflammation | 1.05578241 |
98 | MP0002735_abnormal_chemical_nociception | 1.05118284 |
99 | MP0002089_abnormal_postnatal_growth/wei | 1.04711680 |
100 | MP0003787_abnormal_imprinting | 1.04405236 |
101 | MP0000858_altered_metastatic_potential | 1.04355364 |
102 | MP0004233_abnormal_muscle_weight | 1.02697561 |
103 | MP0002882_abnormal_neuron_morphology | 1.01594649 |
104 | MP0005623_abnormal_meninges_morphology | 1.00472807 |
105 | MP0004145_abnormal_muscle_electrophysio | 1.00426319 |
106 | MP0002269_muscular_atrophy | 0.98800521 |
107 | MP0005000_abnormal_immune_tolerance | 0.98154968 |
108 | MP0001851_eye_inflammation | 0.97382273 |
109 | MP0005535_abnormal_body_temperature | 0.96953094 |
110 | MP0000685_abnormal_immune_system | 0.96427601 |
111 | MP0000778_abnormal_nervous_system | 0.95795902 |
112 | MP0003634_abnormal_glial_cell | 0.95661627 |
113 | MP0003300_gastrointestinal_ulcer | 0.94656761 |
114 | MP0000003_abnormal_adipose_tissue | 0.94361291 |
115 | MP0005275_abnormal_skin_tensile | 0.94168374 |
116 | MP0001502_abnormal_circadian_rhythm | 0.93025366 |
117 | MP0001790_abnormal_immune_system | 0.92209697 |
118 | MP0005387_immune_system_phenotype | 0.92209697 |
119 | MP0005646_abnormal_pituitary_gland | 0.90668429 |
120 | * MP0002152_abnormal_brain_morphology | 0.89732949 |
121 | MP0005023_abnormal_wound_healing | 0.89667499 |
122 | MP0001800_abnormal_humoral_immune | 0.89477577 |
123 | MP0003183_abnormal_peptide_metabolism | 0.89196373 |
124 | MP0005620_abnormal_muscle_contractility | 0.89175842 |
125 | MP0009333_abnormal_splenocyte_physiolog | 0.88804392 |
126 | MP0003303_peritoneal_inflammation | 0.88784886 |
127 | MP0010329_abnormal_lipoprotein_level | 0.87754555 |
128 | MP0010155_abnormal_intestine_physiology | 0.87420554 |
129 | MP0002653_abnormal_ependyma_morphology | 0.87379024 |
130 | MP0003828_pulmonary_edema | 0.87062407 |
131 | MP0008872_abnormal_physiological_respon | 0.86221234 |
132 | MP0002069_abnormal_eating/drinking_beha | 0.84747326 |
133 | MP0002254_reproductive_system_inflammat | 0.84347041 |
134 | MP0002971_abnormal_brown_adipose | 0.84183031 |
135 | MP0005058_abnormal_lysosome_morphology | 0.81861560 |
136 | MP0002972_abnormal_cardiac_muscle | 0.80420100 |
137 | MP0002420_abnormal_adaptive_immunity | 0.80353941 |
138 | MP0005375_adipose_tissue_phenotype | 0.80124199 |
139 | MP0002723_abnormal_immune_serum | 0.80102912 |
140 | MP0005390_skeleton_phenotype | 0.80086230 |
141 | MP0001819_abnormal_immune_cell | 0.79768872 |
142 | MP0002229_neurodegeneration | 0.78405429 |
143 | MP0003632_abnormal_nervous_system | 0.77636901 |
144 | MP0004085_abnormal_heartbeat | 0.76088835 |
145 | MP0000920_abnormal_myelination | 0.74621723 |
146 | MP0000249_abnormal_blood_vessel | 0.73398293 |
147 | MP0003191_abnormal_cellular_cholesterol | 0.72768718 |
148 | MP0005166_decreased_susceptibility_to | 0.72182697 |
149 | MP0002234_abnormal_pharynx_morphology | 0.72134189 |
150 | MP0002837_dystrophic_cardiac_calcinosis | 0.71506712 |
151 | MP0001348_abnormal_lacrimal_gland | 0.68325096 |
152 | MP0003252_abnormal_bile_duct | 0.67655001 |
153 | MP0002090_abnormal_vision | 0.67482938 |
154 | MP0003137_abnormal_impulse_conducting | 0.67466289 |
155 | MP0005076_abnormal_cell_differentiation | 0.67454173 |
156 | MP0002078_abnormal_glucose_homeostasis | 0.64926263 |
157 | MP0004087_abnormal_muscle_fiber | 0.64383695 |
158 | MP0002118_abnormal_lipid_homeostasis | 0.62164267 |
159 | MP0001765_abnormal_ion_homeostasis | 0.61376268 |
160 | MP0005670_abnormal_white_adipose | 0.60073490 |
161 | MP0001984_abnormal_olfaction | 0.59347687 |
162 | MP0005666_abnormal_adipose_tissue | 0.59290410 |
163 | MP0001849_ear_inflammation | 0.59289302 |
164 | MP0002877_abnormal_melanocyte_morpholog | 0.58845759 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.01287989 |
2 | Visual hallucinations (HP:0002367) | 4.38419640 |
3 | Abnormality of the lower motor neuron (HP:0002366) | 4.19008275 |
4 | Focal motor seizures (HP:0011153) | 4.14676775 |
5 | Focal seizures (HP:0007359) | 3.97901659 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 3.91036077 |
7 | Increased connective tissue (HP:0009025) | 3.71076400 |
8 | Supranuclear gaze palsy (HP:0000605) | 3.52024546 |
9 | Action tremor (HP:0002345) | 3.49868129 |
10 | Increased variability in muscle fiber diameter (HP:0003557) | 3.45270957 |
11 | Postural instability (HP:0002172) | 3.34615241 |
12 | Ankle clonus (HP:0011448) | 3.33557661 |
13 | Hemiplegia (HP:0002301) | 3.33063772 |
14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.27442256 |
15 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.26948907 |
16 | Cerebral aneurysm (HP:0004944) | 3.22916136 |
17 | Myopathic facies (HP:0002058) | 3.16063130 |
18 | Insomnia (HP:0100785) | 3.14498314 |
19 | Depression (HP:0000716) | 3.11141055 |
20 | Distal lower limb amyotrophy (HP:0008944) | 3.02320420 |
21 | Eczematoid dermatitis (HP:0000976) | 3.00686495 |
22 | Hyperacusis (HP:0010780) | 2.99408695 |
23 | Upper limb amyotrophy (HP:0009129) | 2.97798931 |
24 | Distal upper limb amyotrophy (HP:0007149) | 2.97798931 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 2.96704143 |
26 | Distal lower limb muscle weakness (HP:0009053) | 2.92779909 |
27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.89140216 |
28 | Broad face (HP:0000283) | 2.88947087 |
29 | Muscle fiber splitting (HP:0003555) | 2.87459946 |
30 | Round ear (HP:0100830) | 2.85042550 |
31 | Protrusio acetabuli (HP:0003179) | 2.83052877 |
32 | Abnormal social behavior (HP:0012433) | 2.80908597 |
33 | Impaired social interactions (HP:0000735) | 2.80908597 |
34 | Nemaline bodies (HP:0003798) | 2.79103513 |
35 | Dysmetric saccades (HP:0000641) | 2.76569749 |
36 | Papilledema (HP:0001085) | 2.74130332 |
37 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.71520995 |
38 | Hand muscle atrophy (HP:0009130) | 2.71340889 |
39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69804239 |
40 | Annular pancreas (HP:0001734) | 2.69439909 |
41 | Asymmetric septal hypertrophy (HP:0001670) | 2.68472598 |
42 | Stridor (HP:0010307) | 2.68268467 |
43 | Resting tremor (HP:0002322) | 2.67909560 |
44 | Poor eye contact (HP:0000817) | 2.67847909 |
45 | Bundle branch block (HP:0011710) | 2.67385679 |
46 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.66633999 |
47 | Pointed chin (HP:0000307) | 2.59629870 |
48 | Elfin facies (HP:0004428) | 2.58390587 |
49 | Mutism (HP:0002300) | 2.56510628 |
50 | Urinary urgency (HP:0000012) | 2.54985025 |
51 | Hyporeflexia of lower limbs (HP:0002600) | 2.51330968 |
52 | Difficulty climbing stairs (HP:0003551) | 2.47450428 |
53 | Torticollis (HP:0000473) | 2.46658012 |
54 | Intention tremor (HP:0002080) | 2.46550767 |
55 | Ulnar deviation of the wrist (HP:0003049) | 2.46275584 |
56 | Cerebral inclusion bodies (HP:0100314) | 2.43320975 |
57 | Ventricular fibrillation (HP:0001663) | 2.41327102 |
58 | Impaired smooth pursuit (HP:0007772) | 2.39653945 |
59 | Cervical subluxation (HP:0003308) | 2.38666653 |
60 | Thin bony cortex (HP:0002753) | 2.36292626 |
61 | Bradykinesia (HP:0002067) | 2.34762554 |
62 | Epileptic encephalopathy (HP:0200134) | 2.34409507 |
63 | Progressive cerebellar ataxia (HP:0002073) | 2.33813016 |
64 | Neoplasm of the heart (HP:0100544) | 2.33573266 |
65 | Generalized tonic-clonic seizures (HP:0002069) | 2.31743590 |
66 | Macroorchidism (HP:0000053) | 2.31218482 |
67 | Rapidly progressive (HP:0003678) | 2.29860737 |
68 | Turricephaly (HP:0000262) | 2.29257502 |
69 | Dysdiadochokinesis (HP:0002075) | 2.29118542 |
70 | Status epilepticus (HP:0002133) | 2.28891974 |
71 | Spastic gait (HP:0002064) | 2.28553463 |
72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26119895 |
73 | Increased IgE level (HP:0003212) | 2.26012656 |
74 | Anxiety (HP:0000739) | 2.26003881 |
75 | Spinal rigidity (HP:0003306) | 2.24043696 |
76 | Dysmetria (HP:0001310) | 2.23694850 |
77 | Neuronal loss in central nervous system (HP:0002529) | 2.20973732 |
78 | Focal dystonia (HP:0004373) | 2.18621951 |
79 | Ulnar bowing (HP:0003031) | 2.16998713 |
80 | Bulbar palsy (HP:0001283) | 2.16627951 |
81 | Lymphangioma (HP:0100764) | 2.16267508 |
82 | Absence seizures (HP:0002121) | 2.16156359 |
83 | Easy fatigability (HP:0003388) | 2.15780460 |
84 | Genetic anticipation (HP:0003743) | 2.14657473 |
85 | Premature rupture of membranes (HP:0001788) | 2.14570646 |
86 | Atonic seizures (HP:0010819) | 2.14367730 |
87 | Clonus (HP:0002169) | 2.13157854 |
88 | Mitral regurgitation (HP:0001653) | 2.12300991 |
89 | Colitis (HP:0002583) | 2.11801593 |
90 | Neurofibrillary tangles (HP:0002185) | 2.10558266 |
91 | Gingivitis (HP:0000230) | 2.10422602 |
92 | Fragile skin (HP:0001030) | 2.10413676 |
93 | Aneurysm (HP:0002617) | 2.10004038 |
94 | EMG: myopathic abnormalities (HP:0003458) | 2.09942153 |
95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07764805 |
96 | Truncal ataxia (HP:0002078) | 2.06905595 |
97 | Hemiparesis (HP:0001269) | 2.06475334 |
98 | Lower limb amyotrophy (HP:0007210) | 2.06370971 |
99 | Craniofacial dystonia (HP:0012179) | 2.04220144 |
100 | Renovascular hypertension (HP:0100817) | 2.02851691 |
101 | Abnormality of the periventricular white matter (HP:0002518) | 2.02171961 |
102 | Metaphyseal cupping (HP:0003021) | 2.01597395 |
103 | Slender build (HP:0001533) | 2.01472877 |
104 | Obstructive sleep apnea (HP:0002870) | 2.01374521 |
105 | Achilles tendon contracture (HP:0001771) | 2.01224924 |
106 | Enlarged penis (HP:0000040) | 2.00488911 |
107 | Abnormal eating behavior (HP:0100738) | 2.00163096 |
108 | J-shaped sella turcica (HP:0002680) | 2.00096805 |
109 | Dialeptic seizures (HP:0011146) | 1.99097837 |
110 | Febrile seizures (HP:0002373) | 1.98634595 |
111 | Hemorrhage of the eye (HP:0011885) | 1.98151189 |
112 | Apathy (HP:0000741) | 1.97922158 |
113 | Lower limb muscle weakness (HP:0007340) | 1.97534354 |
114 | Biconcave vertebral bodies (HP:0004586) | 1.97239326 |
115 | Ventricular tachycardia (HP:0004756) | 1.97226970 |
116 | Dysostosis multiplex (HP:0000943) | 1.96746202 |
117 | Abnormality of the Achilles tendon (HP:0005109) | 1.95987100 |
118 | Broad metatarsal (HP:0001783) | 1.95799188 |
119 | Cellulitis (HP:0100658) | 1.93835785 |
120 | Striae distensae (HP:0001065) | 1.93018312 |
121 | Amyotrophic lateral sclerosis (HP:0007354) | 1.92471317 |
122 | Atrophic scars (HP:0001075) | 1.90264040 |
123 | Emphysema (HP:0002097) | 1.89499751 |
124 | Polygenic inheritance (HP:0010982) | 1.88323007 |
125 | Gaze-evoked nystagmus (HP:0000640) | 1.87686878 |
126 | Scanning speech (HP:0002168) | 1.87333152 |
127 | Dilatation of the ascending aorta (HP:0005111) | 1.86789184 |
128 | Difficulty running (HP:0009046) | 1.86755472 |
129 | Megalencephaly (HP:0001355) | 1.86676487 |
130 | Neck muscle weakness (HP:0000467) | 1.85696592 |
131 | Impaired vibratory sensation (HP:0002495) | 1.85575144 |
132 | Rigidity (HP:0002063) | 1.84921653 |
133 | Abnormality of binocular vision (HP:0011514) | 1.84763389 |
134 | Diplopia (HP:0000651) | 1.84763389 |
135 | Joint stiffness (HP:0001387) | 1.83787965 |
136 | Muscle stiffness (HP:0003552) | 1.82425522 |
137 | Stereotypic behavior (HP:0000733) | 1.81174065 |
138 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80886119 |
139 | Bronchomalacia (HP:0002780) | 1.80450864 |
140 | Sudden death (HP:0001699) | 1.80110411 |
141 | Foot dorsiflexor weakness (HP:0009027) | 1.79969715 |
142 | Aortic aneurysm (HP:0004942) | 1.79616754 |
143 | Long toe (HP:0010511) | 1.79184611 |
144 | Onion bulb formation (HP:0003383) | 1.78955630 |
145 | Overriding aorta (HP:0002623) | 1.78938779 |
146 | Hypercortisolism (HP:0001578) | 1.78769422 |
147 | Diminished motivation (HP:0000745) | 1.78343228 |
148 | Abnormality of the astrocytes (HP:0100707) | 1.77525136 |
149 | Astrocytoma (HP:0009592) | 1.77525136 |
150 | Distal arthrogryposis (HP:0005684) | 1.76473526 |
151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75985935 |
152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75985935 |
153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75985935 |
154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75810000 |
155 | Mucopolysacchariduria (HP:0008155) | 1.75810000 |
156 | Shallow orbits (HP:0000586) | 1.75399873 |
157 | Axonal loss (HP:0003447) | 1.75327427 |
158 | Global brain atrophy (HP:0002283) | 1.75157109 |
159 | Tetraplegia (HP:0002445) | 1.75014955 |
160 | Exercise-induced myalgia (HP:0003738) | 1.74644325 |
161 | Disproportionate tall stature (HP:0001519) | 1.73844875 |
162 | EMG: neuropathic changes (HP:0003445) | 1.73779527 |
163 | Gastrointestinal inflammation (HP:0004386) | 1.73412875 |
164 | Retinal atrophy (HP:0001105) | 1.73006291 |
165 | Malnutrition (HP:0004395) | 1.72042025 |
166 | Aortic regurgitation (HP:0001659) | 1.71551277 |
167 | Nuclear cataract (HP:0100018) | 1.70723016 |
168 | Abnormality of macrophages (HP:0004311) | 1.70655815 |
169 | Lower limb asymmetry (HP:0100559) | 1.70517000 |
170 | Hypertriglyceridemia (HP:0002155) | 1.70384678 |
171 | Amblyopia (HP:0000646) | 1.69147184 |
172 | Abnormality of the fingertips (HP:0001211) | 1.68766844 |
173 | Mitral valve prolapse (HP:0001634) | 1.68677791 |
174 | Abnormality of the foot musculature (HP:0001436) | 1.67480000 |
175 | Vertebral compression fractures (HP:0002953) | 1.67182155 |
176 | Atelectasis (HP:0100750) | 1.66675129 |
177 | Spinal canal stenosis (HP:0003416) | 1.65837826 |
178 | Abnormality of the nasal mucosa (HP:0000433) | 1.65045371 |
179 | Recurrent abscess formation (HP:0002722) | 1.64927295 |
180 | Blue sclerae (HP:0000592) | 1.64527458 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 4.54964696 |
2 | PRKD3 | 2.96574089 |
3 | EPHA4 | 2.95479727 |
4 | NTRK3 | 2.85773925 |
5 | PRPF4B | 2.85728516 |
6 | TRIB3 | 2.82771837 |
7 | DAPK2 | 2.58707034 |
8 | KSR2 | 2.57155528 |
9 | MAP4K1 | 2.19230841 |
10 | MAP2K3 | 2.13564858 |
11 | CAMKK1 | 2.10139077 |
12 | SMG1 | 2.07042759 |
13 | MARK1 | 1.99341836 |
14 | PAK6 | 1.96095500 |
15 | RIPK1 | 1.92090381 |
16 | NTRK1 | 1.87644680 |
17 | PKN2 | 1.85683053 |
18 | SIK2 | 1.81129039 |
19 | MINK1 | 1.81006980 |
20 | EPHB1 | 1.80409588 |
21 | NTRK2 | 1.78049695 |
22 | EEF2K | 1.65909902 |
23 | MAP3K13 | 1.64846825 |
24 | TYRO3 | 1.63271041 |
25 | MAP3K4 | 1.61994714 |
26 | STK38 | 1.61658882 |
27 | MAP3K11 | 1.54045460 |
28 | ICK | 1.47752631 |
29 | MAP3K6 | 1.43955546 |
30 | LMTK2 | 1.39418826 |
31 | TAOK1 | 1.38158476 |
32 | DAPK1 | 1.37997713 |
33 | PRKCH | 1.33624803 |
34 | PDGFRA | 1.33494466 |
35 | MAP2K4 | 1.32775906 |
36 | OBSCN | 1.30053171 |
37 | ZAP70 | 1.30039640 |
38 | CAMK1G | 1.29038268 |
39 | TYK2 | 1.23198781 |
40 | RET | 1.23073573 |
41 | ALK | 1.22259812 |
42 | CDK5 | 1.18733935 |
43 | PHKG2 | 1.16536663 |
44 | PHKG1 | 1.16536663 |
45 | RIPK4 | 1.13855533 |
46 | SCYL2 | 1.10387208 |
47 | MAP3K2 | 1.09121895 |
48 | KSR1 | 1.08813228 |
49 | MAP3K3 | 1.06365612 |
50 | STK11 | 1.03952151 |
51 | TBK1 | 1.03633869 |
52 | CSK | 0.98597834 |
53 | MAP3K7 | 0.97883709 |
54 | FES | 0.97396971 |
55 | CAMK1 | 0.96360839 |
56 | NEK1 | 0.96074111 |
57 | BLK | 0.95827227 |
58 | CAMKK2 | 0.95817092 |
59 | MARK2 | 0.95672936 |
60 | EPHA2 | 0.94094098 |
61 | PTK6 | 0.91279229 |
62 | RPS6KC1 | 0.87963354 |
63 | RPS6KL1 | 0.87963354 |
64 | MAPK7 | 0.87950201 |
65 | CDK12 | 0.87232210 |
66 | TGFBR2 | 0.85892307 |
67 | MAP3K1 | 0.85379847 |
68 | UHMK1 | 0.85335618 |
69 | ERN1 | 0.84789657 |
70 | GRK6 | 0.83796822 |
71 | DYRK1B | 0.82972042 |
72 | PDK1 | 0.82940187 |
73 | SGK3 | 0.82865408 |
74 | PINK1 | 0.80948334 |
75 | TESK1 | 0.79615210 |
76 | LATS2 | 0.78066052 |
77 | ARAF | 0.77667260 |
78 | CAMK4 | 0.74299890 |
79 | PDPK1 | 0.73881910 |
80 | GRK5 | 0.73391869 |
81 | TAOK2 | 0.73307118 |
82 | IRAK3 | 0.69753796 |
83 | CDC42BPA | 0.69469704 |
84 | CAMK1D | 0.69288134 |
85 | BTK | 0.69159550 |
86 | SIK1 | 0.67802526 |
87 | RPS6KA6 | 0.67577494 |
88 | MAP3K10 | 0.66560611 |
89 | MST1R | 0.66509288 |
90 | MAPK15 | 0.66323324 |
91 | MAPKAPK3 | 0.66255457 |
92 | SIK3 | 0.66194879 |
93 | DDR2 | 0.65923304 |
94 | PNCK | 0.65270534 |
95 | BMX | 0.61947931 |
96 | HCK | 0.61684295 |
97 | MAPK11 | 0.60763379 |
98 | RPS6KA2 | 0.60685585 |
99 | TTN | 0.60350496 |
100 | PRKD2 | 0.60101130 |
101 | JAK3 | 0.60051906 |
102 | RAF1 | 0.58022298 |
103 | PRKCG | 0.57535529 |
104 | IRAK4 | 0.57388265 |
105 | PTK2 | 0.55677873 |
106 | CDK15 | 0.55069797 |
107 | PAK3 | 0.54576007 |
108 | MAPK4 | 0.54316708 |
109 | MAP2K6 | 0.53927984 |
110 | DAPK3 | 0.52976405 |
111 | PDGFRB | 0.52729246 |
112 | MAPK12 | 0.52558776 |
113 | FGFR3 | 0.52287475 |
114 | PTK2B | 0.49880195 |
115 | TNK2 | 0.49462097 |
116 | DMPK | 0.49331358 |
117 | MAP2K2 | 0.49023352 |
118 | FYN | 0.48854636 |
119 | CDK18 | 0.48837948 |
120 | RPS6KA3 | 0.48664225 |
121 | JAK2 | 0.48462374 |
122 | FGFR4 | 0.47137453 |
123 | SGK223 | 0.47034762 |
124 | SGK494 | 0.47034762 |
125 | CDK11A | 0.46971809 |
126 | MTOR | 0.46498408 |
127 | JAK1 | 0.46365629 |
128 | PRKD1 | 0.45901251 |
129 | PRKCZ | 0.45175705 |
130 | PRKG2 | 0.44532452 |
131 | MAP3K14 | 0.43804057 |
132 | SGK1 | 0.43276469 |
133 | HIPK2 | 0.42390832 |
134 | EPHA3 | 0.41676075 |
135 | CDK14 | 0.40735563 |
136 | MATK | 0.40680545 |
137 | FGFR2 | 0.40638615 |
138 | FGR | 0.40287182 |
139 | SGK2 | 0.39994318 |
140 | ITK | 0.39566162 |
141 | PRKAA2 | 0.38921706 |
142 | LCK | 0.38273954 |
143 | MAPK10 | 0.35817929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74451075 |
2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.43405633 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41728210 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33138711 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23259684 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02689617 |
7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.98995581 |
8 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.90279767 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.87700124 |
10 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85758979 |
11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81565881 |
12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79575913 |
13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77529293 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.76450972 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.73014050 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72487284 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.66864404 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66817657 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.58418111 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58125448 |
21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57654749 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55067455 |
23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54180098 |
24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52645181 |
25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49056189 |
26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48356072 |
27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43512411 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40354613 |
29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37493822 |
30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37403531 |
31 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.36039931 |
32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35542697 |
33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34025340 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30326560 |
35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28426225 |
36 | Renin secretion_Homo sapiens_hsa04924 | 1.28143647 |
37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27484045 |
38 | Glioma_Homo sapiens_hsa05214 | 1.23589436 |
39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18879847 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.18832827 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17082782 |
42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14823940 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13960174 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13151592 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12194035 |
46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10041425 |
47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09307530 |
48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09240758 |
49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07646998 |
50 | Gap junction_Homo sapiens_hsa04540 | 1.07003936 |
51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06784304 |
52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05139243 |
53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05010778 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02041067 |
55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00465347 |
56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98867172 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98803017 |
58 | Long-term depression_Homo sapiens_hsa04730 | 0.95988680 |
59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95331740 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94834958 |
61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93967737 |
62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93880670 |
63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93827478 |
64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92356489 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91833044 |
66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90721741 |
67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90702538 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89641498 |
69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89401372 |
70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89259400 |
71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88633378 |
72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88139921 |
73 | Taste transduction_Homo sapiens_hsa04742 | 0.87819276 |
74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87500349 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86992666 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86652056 |
77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86381319 |
78 | Malaria_Homo sapiens_hsa05144 | 0.85677852 |
79 | Tuberculosis_Homo sapiens_hsa05152 | 0.83169023 |
80 | Melanogenesis_Homo sapiens_hsa04916 | 0.82668959 |
81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80955293 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79897759 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.79042525 |
84 | Bladder cancer_Homo sapiens_hsa05219 | 0.78930832 |
85 | Prion diseases_Homo sapiens_hsa05020 | 0.78925196 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77926367 |
87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77694683 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76313862 |
89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75321797 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74100841 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.74006470 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.73142524 |
93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72995104 |
94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71887783 |
95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71704449 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.71617458 |
97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71111391 |
98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66582018 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65454472 |
100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65177349 |
101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65045470 |
102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64885278 |
103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62972526 |
104 | Lysosome_Homo sapiens_hsa04142 | 0.61399300 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60542078 |
106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60345141 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58978978 |
108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58871657 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58687180 |
110 | Influenza A_Homo sapiens_hsa05164 | 0.57540346 |
111 | Axon guidance_Homo sapiens_hsa04360 | 0.56314214 |
112 | Lysine degradation_Homo sapiens_hsa00310 | 0.55858152 |
113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55543571 |
114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55516776 |
115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54809133 |
116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54568773 |
117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54189812 |
118 | Hepatitis B_Homo sapiens_hsa05161 | 0.54132316 |
119 | Apoptosis_Homo sapiens_hsa04210 | 0.53311342 |
120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53038719 |
121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52880810 |
122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52717074 |
123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50915874 |
124 | Platelet activation_Homo sapiens_hsa04611 | 0.50389997 |
125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50355293 |
126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50164388 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48872641 |
128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45912730 |
129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44937095 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44544308 |
131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44436655 |
132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43128626 |
133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39890537 |
134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39431324 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37921317 |
136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37803568 |
137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37599953 |
138 | Focal adhesion_Homo sapiens_hsa04510 | 0.36086682 |
139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35986658 |
140 | Amoebiasis_Homo sapiens_hsa05146 | 0.35727591 |